Richard F. Pops Net Worth Overview
Richard F. Pops is the chairman and CEO of Alkermes plc, a biopharmaceutical company focused on central nervous system and oncology therapies. His estimated net worth is primarily tied to his equity holdings in Alkermes and related compensation packages. Public filings and financial disclosures provide the most recent figures on his compensation and stock ownership. For detailed executive compensation data, see the latest proxy filings at SEC EDGAR.
Executive wealth for leaders like Richard F. Pops is often reported through annual proxy statements and regulatory filings. These documents disclose salary, bonuses, stock awards, and option exercises. The value of his holdings can fluctuate with Alkermes stock price movements and vesting schedules. Accurate net worth estimates rely on these public disclosures rather than speculative estimates.
Career and Compensation at Alkermes
Richard F. Pops has served as chairman and chief executive officer of Alkermes for multiple years, guiding the company through product launches and pipeline expansions. His compensation typically includes a base salary, annual bonus, equity awards, and long-term incentive plans. The company reports these figures in its annual proxy statement filed with the SEC.
Key Compensation Components
His total annual compensation includes a combination of cash and equity, with stock awards representing a significant portion. These awards are designed to align executive incentives with long-term shareholder value. Specific dollar amounts are disclosed in the DEF14A filing available on the SEC website.
Alkermes Company Background and Market Position
Alkermes plc is a biopharmaceutical company headquartered in Dublin, Ireland, with operations in the United States. The company develops therapies for CNS disorders, including multiple sclerosis and depression, as well as oncology products. Its commercial products include injectable formulations for conditions such as schizophrenia and bipolar disorder.
The company is publicly traded and subject to regular financial reporting requirements. Investors and analysts track Alkermes stock performance and pipeline progress as key indicators of executive wealth. For additional company information, visit the official investor relations page at Alkermes Investor Relations.